✦ LIBER ✦

Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients

✍ Scribed by Tanaka, Tomohiro; Selzner, Nazia; Therapondos, George; Renner, Eberhard L.; Lilly, Leslie B.

Book ID: 119839753
Publisher: Springer
Year: 2012
Tongue: English
Weight: 106 KB
Volume: 26
Category: Article
ISSN: 0934-0874
DOI: 10.1111/j.1432-2277.2012.01571.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term maintenance of sustained virol

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C

✍ Ponziani, Francesca Romana; Viganò, Raffaella; Iemmolo, Rosa Maria; Donato, Mari 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 521 KB

Factors Associated With Sustained Virolo

Factors Associated With Sustained Virological Response in Liver Transplant Recipients With Recurrent Hepatitis C

✍ A.A. Pillai; V.S. Lee; E. Wang; M.E. Rinella; J. Levitsky 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Long-term, maintenance MMF monotherapy i

Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C

✍ Tommaso Maria Manzia; Roberta Angelico; Luca Toti; Maria Irene Bellini; Daniele 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 317 KB

Long-term ribavirin therapy for recurren

Long-term ribavirin therapy for recurrent hepatitis C after liver transplantation

✍ A.A. Aljumah; M.S. Cattral; P.D. Greig; I.R. Wanless; M. Krajden; A.W. Hemmings; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Long-term antiviral treatment for recurr

Long-term antiviral treatment for recurrent hepatitis C after liver transplantation

✍ Valentina Rosa Bertuzzo; Matteo Cescon; Maria Cristina Morelli; Paolo Di Gioia; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Long-term antiviral therapy for recurren

Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: Biochemical, virological, and histological impact

✍ Thomas Walter; Jean-Yves Scoazec; Olivier Guillaud; Valérie Hervieu; Philippe Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 1 views

More than 50% of patients with a recurrent posttransplant hepatitis C virus infection fail to respond to antiviral treatment. The aim of this study was to evaluate the interest of a long-term antiviral treatment maintained for more than 48 weeks. Seventy treated patients, with a histological follow-